Proscar
Proscar contains finasteride, a 5-alpha-reductase inhibitor that reduces the conversion of testosterone into dihydrotestosterone (DHT). Lowering DHT levels can help reduce prostate enlargement and improve urinary symptoms associated with benign prostatic hyperplasia (BPH).
Finasteride may gradually reduce prostate size and lower the risk of urinary retention or the need for prostate-related surgery in appropriate patients.
Key Information
- Contains finasteride
- 5-alpha-reductase inhibitor
- Used primarily for benign prostatic hyperplasia
- Helps reduce prostate size
- Oral tablet formulation
- Prescription medicine
Active Ingredient
Finasteride
Strength
5mg
Dosage Form
Film-coated tablet
Medical Uses
Proscar is primarily used to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate. It can improve urinary flow and reduce symptoms such as difficulty starting urination and frequent or urgent urination.
Directions for Use
Take only as prescribed by a qualified healthcare professional. Finasteride is generally taken once daily and may be taken with or without food.
The therapeutic effect develops gradually and may require several months of continued treatment. Do not change the dose or discontinue treatment without medical advice.
Safety Information
Possible adverse effects include decreased libido, erectile difficulties, reduced ejaculate volume, and changes in ejaculation. Some sexual adverse effects may persist after discontinuation in certain patients.
Finasteride can lower prostate-specific antigen (PSA) levels, which may affect prostate cancer screening. Healthcare professionals should be informed that finasteride is being taken when interpreting PSA results.
Pregnant women should not handle crushed or broken tablets because finasteride can potentially harm a developing male fetus.
Storage
Store according to the manufacturer’s instructions, protected from excessive heat, moisture, and direct sunlight. Keep out of reach of children.














Reviews
There are no reviews yet.